| |
| |
|
| Insider
Information: |
Huang Dennis Karl |
| Relationship: |
|
| City: |
Novato |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
83,002 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,593,987 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
83,002 |
|
|
| Total
Value |
$3,593,987 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
6
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
6
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-6.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -169.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ultragenyx Pharmaceutical Inc |
RARE |
|
2024-03-01 |
83,002 |
2015-05-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2024-03-01 |
4 |
D |
$53.69 |
$25,234 |
D/D |
(470) |
83,002 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2024-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
18,757 |
83,472 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2023-03-01 |
4 |
D |
$45.65 |
$483,844 |
D/D |
(10,599) |
64,715 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2023-03-01 |
4 |
S |
$45.65 |
$17,758 |
D/D |
(389) |
75,314 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2023-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
24,663 |
75,703 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2022-03-01 |
4 |
S |
$66.62 |
$215,449 |
D/D |
(3,234) |
36,914 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
See Remarks |
• – – |
2022-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
14,000 |
51,040 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2021-10-14 |
4 |
S |
$81.14 |
$29,048 |
D/D |
(358) |
40,148 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2021-05-06 |
4 |
S |
$113.68 |
$41,266 |
D/D |
(363) |
40,506 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2021-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,136 |
44,835 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2021-03-01 |
4 |
S |
$138.18 |
$587,956 |
D/D |
(4,255) |
40,761 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2020-10-14 |
4 |
S |
$88.00 |
$23,056 |
D/D |
(262) |
34,699 |
0 |
% |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2020-06-01 |
4 |
D |
$69.38 |
$18,178 |
D/D |
(262) |
34,961 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2020-05-06 |
4 |
D |
$66.26 |
$16,432 |
D/D |
(248) |
34,979 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2020-04-19 |
4 |
D |
$58.57 |
$14,525 |
D/D |
(248) |
35,227 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2020-03-01 |
4 |
D |
$56.08 |
$99,766 |
D/D |
(1,779) |
35,475 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2020-03-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,434 |
37,013 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-10-14 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
23,579 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-06-01 |
4 |
D |
$54.93 |
$14,282 |
D/D |
(260) |
22,145 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-05-06 |
4 |
A |
$0.00 |
$0 |
D/D |
1,434 |
22,405 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-05-05 |
4 |
D |
$67.99 |
$44,126 |
D/D |
(649) |
20,971 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-04-19 |
4 |
D |
$64.43 |
$15,979 |
D/D |
(248) |
21,445 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-03-05 |
4/A |
S |
$65.52 |
$41,016 |
D/D |
(626) |
21,693 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-03-01 |
4/A |
A |
$0.00 |
$0 |
D/D |
6,000 |
22,319 |
0 |
- |
|
| RARE |
Ultragenyx Pharmaceutical... |
EVP & Chief Tech Ops Officer |
• – – |
2019-03-01 |
4 |
D |
$67.55 |
$41,003 |
D/D |
(607) |
21,711 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
